Original Article

Effectiveness of Pharmacist and Physician Collaboration in the Treatment of Type 2 Diabetes Mellitus With Severe Insulin Resistance Using U-500 Insulin

Objectives: To evaluate the effectiveness of pharmacist–physician collaboration in the treatment of type 2 diabetes mellitus (DM) with severe insulin resistance, using 500 U/mL concentrated regular insulin (U-500) in a primary care clinic that is not staffed by an endocrinologist. Methods: A retrospective chart review was conducted searching for patients…

Posted in: insulin resistance 4 interprofessional collaboration 3 pharmacist 4 type 2 diabetes mellitus 13

Review Article

Statin-Associated Diabetes Mellitus: Review and Clinical Guide

A small but significant link between new-onset diabetes mellitus (NOD) and statin therapy was noted with rosuvastatin users in the Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin study. Since then multiple analyses have further confirmed this association, with most studies demonstrating a modest…

Posted in: Cardiovascular Disease 27 diabetes mellitus 37 insulin resistance 4 Statins 8 type 2 diabetes mellitus 13

Original Article

Effect of Helicobacter pylori Eradication on Insulin Resistance, Serum Lipids and Low-Grade Inflammation

Background/Aim: Many studies have revealed a close relationship between Helicobacter pylori (HP) infection and insulin resistance. The aim of this study was to investigate the effects of HP eradication on insulin resistance, serum lipids and low-grade inflammation. Materials and Methods: This was a prospective, open-label, single-center study which consisted of…

Posted in: eradication 3 insulin resistance 4

Review Article

Type 2 Diabetes: Epidemiologic Trends, Evolving Pathogenic Concepts, and Recent Changes in Therapeutic Approach

The prevalence of type 2 diabetes has assumed epidemic dimensions. Children are now vulnerable to a disease that was once the exclusive domain of adulthood. Increased body weight and sedentary behavior accelerate insulin resistance and β-cell dysfunction, leading to the clinical manifestation of hyperglycemia. Other cardiovascular risk factors tend to…

Posted in: Cardiovascular Disease 27 insulin resistance 4 metabolic syndrome 8 type 2 diabetes 7
SMA Menu